WHO Recommends Lifestyle Changes Over GLP-1 Drugs for Childhood Obesity | Retatrutide News

The WHO advises prioritizing lifestyle changes over GLP-1 drugs for childhood obesity treatment. This recommendation may impact the use of Retatrutide a...
Weight Loss · October 25, 2026